|
Weaker 1Q for AMAG - Morningstar.com |
Morningstar.comAMAG reported roughly 1700 providers have now purchased the therapeutic, with 60% of demand coming from outside the dialysis setting. ...Canaccord Adams Reiterates a 'Buy' on AMAG Pharmaceuticals (AMAG ... |
|
DaVita shares fall on reimbursement rate concerns - BusinessWeek |
BusinessWeekShares of DaVita Inc., a provider of kidney dialysis services, fell Wednesday after its stock was downgraded on concerns of lower reimbursement rates, ... |
Parole board denies Erik Randall's request for release for kidney transplant - North Lake Tahoe Bonanza |
North Lake Tahoe BonanzaInstead, he's receiving dialysis at a yearly cost of $50000. “The by far preferred course of treatment is a kidney transplant,” Cornell said. ... |
Parole board denies DUI killer Erik Randall's request for release for kidney ... - North Lake Tahoe Bonanza |
North Lake Tahoe BonanzaInstead, he's receiving dialysis at a yearly cost of $50000. “The by far preferred course of treatment is a kidney transplant,” Cornell said. ... |
FDA Safety Changes: Lotrel - Medscape |
MedscapeThe revisions address benazepril-related fetal and neonatal risks; drug interactions; and the potential for renal impairment and angioedema, as well as the ... |
|
|
|
<< Start < Prev 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 Next > End >>
|
Page 1628 of 2630 |